Speaker Information 

Iwona Tongbhoyai

Chief Growth Officer,
FutureMeds

Iwona Tongbhoyai is the Chief Growth Officer at FutureMeds, a leading pan-European network of Dedicated Research Sites operating across six countries, with 29 research sites and decentralized clinical trial (DCT) capabilities supporting studies throughout Europe.
She oversees FutureMeds’ strategic growth and operational excellence, leading key global functions including Feasibility & Proposals, Quality Management, and Decentralized Clinical Trial Operations, while driving the expansion of the company’s dedicated research site network and innovative clinical trial delivery models.
With more than 18 years of experience in clinical research and site management, Iwona has worked closely with pharmaceutical companies, CROs, investigators, and healthcare providers to develop patient-centric solutions that improve study execution, operational efficiency, and patient access to clinical trials. She also brings over seven years of experience in business consulting, specializing in strategic transformation, process optimization, and project management.
As a strong advocate for investigator sites, Iwona is passionate about strengthening their role in advancing medical innovation. Her work focuses on developing scalable, integrated clinical trial models that combine dedicated research sites with decentralized solutions to improve recruitment, operational performance, and patient experience.
Recognizing the increasing complexity of modern clinical trials, she is particularly committed to advancing cross-border clinical research, decentralized trial delivery, operational readiness, and patient diversity. She actively collaborates with sponsors, CROs, healthcare providers, patient organizations, and regulatory stakeholders to design compliant, tailored clinical trial strategies that expand access to research, accelerate study delivery, and improve outcomes for patients across Europe.